Article citationsMore>>

Roemer-Becuwe, C., Vigano, A., Romano, F., Neumann, C., Hanson, J., Quan, H.K., et al. (2003) Safety of Subcutaneous Clodronate and Efficacy in Hypercalcemia of Malignancy: A Novel Route of Administration. Journal of Pain and Symptom Management, 26, 843-848.
https://doi.org/10.1016/S0885-3924(03)00252-5

has been cited by the following article:

• TITLE: Bisphosphonates Zoledronate and Alendronate for the Management of Postmenopausal Osteoporosis

  AUTHORS: IsraaIsraa Ahmed Radwan, Nahed Sedky Korany, Bassant Adel Ezzat

  KEYWORDS: Bisphosphonates, Alendronate, Zoledronate, Postmenopausal Osteoporosis

  JOURNAL NAME: Case Reports in Clinical Medicine, Vol.7 No.5, May 10, 2018

  ABSTRACT: Bisphosphonates are among the most frequently used antiresorptive drugs for the management of postmenopausal osteoporosis. We review here two of the commonly used bisphosphonates zoledronate and alendronate.